SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy, one of the largest compounding pharmacies in the U.S., welcomed New Jersey State Senator Dr. Jeff Van Drew (D-1) to its pharmacy in Swedesboro yesterday. Van Drew toured the state-of-the art facilities, meeting with company executives and constituents to discuss the unique and critical role compounding plays in human and animal medicine, and the Congressional intent that it remain a state-licensed practice.
Van Drew, a dentist, has represented the First Legislative District of New Jersey since 2008 in the New Jersey State Senate and as a member of the General Assembly from 2002–2008. He has held public offices in the state since 1983. For the 2018-19 Senate session, he serves on the Community and Urban Affairs Committee (as chair), the Military and Veterans' Affairs (as vice-chair), the Joint Committee on Housing Affordability and the Intergovernmental Relations Commission. In 2008, he sponsored the Fair Market Drug Pricing Act to establish the New Jersey Rx Card Program to reduce prescription drug prices. Van Drew has declared his candidacy for the United States House of Representatives in the Second Congressional District.
Van Drew said, “My top priority in Congress will be to find ways to bring economic opportunities and good jobs to South Jersey.”
He continued, “It’s important that I know the top employers in the region, such as Wedgewood Pharmacy, to understand how they have been successful on a national scale, and how we as lawmakers can support their success in terms of the tax structure, health insurance system and trade policies.”
Marcy A. Bliss, president and CEO of the company, added, “As a dentist, Dr. Van Drew understands the unique and critical role that compounding pharmacies like ours play in the healthcare system.”
She added, “Our profession is not always understood in state capitols and in Washington. We greatly appreciated his visit to become familiar with how compounding is done at the highest levels of quality, safety and efficiency so he can be an effective voice for us.”
Wedgewood Pharmacy makes customized medications for people and their pets when FDA–manufactured drugs cannot meet their needs. Compounded medications are prescriptions and medication orders that are written by physicians, veterinarians and other legally authorized prescribers, and prepared by specially trained pharmacists and pharmacy technicians.
Compounded medications are created and prepared by specially trained pharmacists and pharmacy technicians in state-of-the-art, accredited facilities. These medications are prescribed and dispensed under orders written by doctors and veterinarians.
About Wedgewood Pharmacy
In its 37 years, Wedgewood Pharmacy has grown from a local community pharmacy to become one of the largest human- and animal-health compounding pharmacies in the United States; it is the leading pharmacy in animal health. Wedgewood Pharmacy serves more than 40,000 prescribers and hundreds of thousands of patients throughout the U.S. every year with animal-health and human-health prescriptions.
George (late) and Lucy Malmberg, both pharmacists, purchased Wedgewood Pharmacy in 1981; the pharmacy was founded in 1980. In June 2016, Chicago-based New Harbor Capital became the majority owner of the company.
Wedgewood Pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB®) for compliance with PCAB pharmacy compounding accreditation standards. PCAB was formed by eight of the nation’s leading pharmacy associations and is a service of Accreditation Commission for Health Care. As a third-party accreditation organization, PCAB has developed the highest national standards against which providers are measured to illustrate their ability to effectively and efficiently deliver quality compounded medications to consumers. The company employs more than 300 people in its state-of-the-art compounding pharmacy in Swedesboro, N.J.